Superworth

Altimmune EPS ALT

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.77
Latest quarter, Q2 FY26
−$0.12
Fiscal year 2025
−$1.00

Altimmune's earnings per share was −$0.77 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.12.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.00n/a
FY2024−$1.34n/a
FY2023−$1.65n/a
FY2022−$1.77n/a
FY2021−$2.35n/a
FY2020−$2.03n/a
FY2019−$1.54n/a
FY2018−$22.59n/a
FY2017−$110.31n/a
FY2016−$42.66n/a
FY2015−$0.18n/a
FY2014−$0.51n/a
FY2013−$0.66n/a
FY2012−$0.33n/a
FY2011−$0.21n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.12n/a−$0.77
Q1 FY26−$0.18n/a−$0.92
Q4 FY25−$0.26n/a−$1.00
Q3 FY25−$0.21n/a−$1.07
Q2 FY25−$0.27n/a−$1.18
Q1 FY25−$0.26n/a−$1.26
Q4 FY24−$0.33n/a−$1.34
Q3 FY24−$0.32n/a−$1.55
Q2 FY24−$0.35n/a−$1.62
Q1 FY24−$0.34n/a−$1.59
Q4 FY23−$0.54n/a−$1.65
Q3 FY23−$0.39n/a−$1.54

Against its peers

Companies in Drug Manufacturers - General nearest Altimmune's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ALTAltimmune−$0.77
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
NATRNatures Sunshine Products$1.01+36% a year
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Altimmune

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.